Investments Opinions A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening By USA News Group Jul 21, 2026 Issued on behalf of Helus Pharma (NASDAQ: HELP) (Cboe CA: HELP)
Investments Opinions A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening By USA News Group Jul 21, 2026 Issued on behalf of Helus Pharma (NASDAQ: HELP) (Cboe CA: HELP)
Investments Opinions A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year By USA News Group Jun 26, 2026 Issued on behalf of Helus Pharmaâ„¢
Investments Opinions A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year By USA News Group Jun 26, 2026 Issued on behalf of Helus Pharmaâ„¢